E2F-1 binding affinity for pRB is not the only determinant of the E2F-1 activity

International Journal of Biological Sciences

Volumn 6, Issue 4, 2010, Pages 382-395

  Sahin, Fikret ^a,b   Sladek, Todd L ^a,c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ANKARA UNIVERSITY   (Turkey)

^c NONE   (United States)

Author keywords

cdc2; Cell cycle; cmyc; dhfr; E2F 1; Rb; TK

Indexed keywords

E2F1 PROTEIN, MOUSE; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ANIMAL; CELL CYCLE; CELL LINE; FLOW CYTOMETRY; GENETICS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METABOLISM; MOUSE; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL CYCLE; CELL LINE; E2F1 TRANSCRIPTION FACTOR; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; PHOSPHORYLATION; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77954644399     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.382     Document Type: Article

References (37)

1. Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 2007,19:649-657.
2. Muller H, Helin K. The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 2000,1470:M1-12.
3. Stengel KR, Thangavel C, Solomon DA, Angus SP, Zheng Y, Knudsen ES. RB/p107/130 pocket proteins: Protein dynamics and interactions with target gene promoters. J Biol Chem 2009;284(29):19265-71.
4. Sun A, Bagella L, Tutton S, Romano G, Giordano A. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway. J Cell Biochem 2007,102:1400-1404.
5. Welch PJ, Wang JY. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev 1995,9:31-46.
6. Hiebert SW, Blake M, Azizkhan J, Nevins JR. Role of E2F transcription factor in E1A-mediated trans activation of cellular genes. J Virol 1991,65:3547-3552.
7. Black AR, Azizkhan-Clifford J. Regulation of E2F: a family of transcription factors involved in proliferation control. Gene 1999,237:281-302.
8. Helin K, Harlow E, Fattaey A. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 1993,13:6501-6508.
9. Sellers WR, Rodgers JW, Kaelin WGJr. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc Natl Acad Sci U S A 1995,92:11544-11548.
10. Fagan R, Flint KJ, Jones N. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 1994,78:799-811.
11. Emili A, Ingles CJ. Promoter-dependent photocross-linking of the acidic transcriptional activator E2F-1 to the TATA-binding protein. J Biol Chem 1995,270:13674-13680.
12. Peeper DS, Keblusek P, Helin K, Toebes M, van der Eb AJ, Zantema A. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro. Oncogene 1995,10:39-48.
13. Vandel L, Kouzarides T. Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase. Embo J 1999,18:4280-4291.
14. Shan B, Durfee T, Lee WH. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc Natl Acad Sci U S A 1996,93:679-684.
15. Cress WD, Johnson DG, Nevins JR. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol Cell Biol 1993,13:6314-6325.
16. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 1988,85:6460-6464.
17. Sladek TL, Jacobberger JW. Rapid titration of retroviral vectors encoding intracellular antigens by flow cytometry. J Virol 1990,64:3135-3138.
18. Sladek TL, Jacobberger JW. Dependence of SV40 large T-antigen cell cycle regulation on T-antigen expression levels. Oncogene 1992,7:1305-1313.
19. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 1992,70:337-350.
20. Sladek TL, Jacobberger JW. Simian virus 40 large T-antigen expression decreases the G1 and increases the G2 + M cell cycle phase durations in exponentially growing cells. J Virol 1992,66:1059-1065.
21. Landau NR, Littman DR. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol 1992,66:5110-5113.
22. Kierstead TD, Tevethia MJ. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J Virol 1993,67:1817-1829.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970,227:680-685.
24. Sahin F, Sladek TL. E2F-1 has dual roles depending on the cell cycle. Int J Biol Sci, 2010;6:116-128.
25. Jat PS, Cepko CL, Mulligan RC, Sharp PA. Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol Cell Biol 1986,6:1204-1217.
26. Yang XH, Sladek TL. Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr 1995,4:195-204.
27. Jacobberger JW, Fogleman D, Lehman JM. Analysis of intracellular antigens by flow cytometry. Cytometry 1986,7:356-364.
28. Kellokumpu-Lehtinen P, Soderstrom KO, Kortekangas A, Nordman E. Ultrastructural effects of irradiation on squamous cell carcinoma of the head and neck. Cancer 1989,63:1108-1118.
29. Nakano T, Oka K. Transition of Ki-67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study. Cancer 1991,68:517-523.
30. Yang XH, Sladek TL. Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA. Biochem Biophys Res Commun 1997,232:336-339.
31. Johnson DG, Cress WD, Jakoi L, Nevins JR. Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A 1994,91:12823-12827.
32. Barrett JC, Crawford BD, Mixter LO, Schechtman LM, Ts'o PO, Pollack R. Correlation of in vitro growth properties and tumorigenicity of Syrian hamster cell lines. Cancer Res 1979,39:1504-1510.
33. Hateboer G, Kerkhoven RM, Shvarts A, Bernards R, Beijersbergen RL. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev 1996,10:2960-2970.
34. Halaban R, Cheng E, Zhang Y, Mandigo CE, Miglarese MR. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1. Oncogene 1998,16:2489-2501.
35. Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001,15:267-285.
36. Campanero MR, Flemington EK. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci U S A 1997,94:2221-2226.
37. Sugarman JL, Schonthal AH, Glass CK. Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription. Mol Cell Biol 1995,15:3282-3290.